Professional Overview

Nancy Van Osselaer is a seasoned professional in the Life Sciences and Healthcare industry, currently serving as a strategic consultant in Early Stage Drug Development and Innovation at Why2What, and Chief Development Officer at Kynexis on a part-time basis. Her key expertise areas include drug development, innovation, and strategic consultancy, with a strong focus on the Life Sciences and Healthcare sector.

Experience Summary

Current Role

Nancy Van Osselaer's current role involves providing strategic consultancy in Early Stage Drug Development and Innovation, leveraging her expertise to drive growth and innovation in the industry. As Chief Development Officer at Kynexis, she plays a pivotal role in shaping the company's development strategy. Her current position has a significant impact on the industry, as she contributes to the development of innovative solutions and strategic partnerships.

Career Progression

Nancy Van Osselaer's career progression is marked by notable roles, including VP Early Development and Innovation at 2 Bridge, Head of Early Development Project Leaders at Galapagos, and Project Leader Development at Galapagos. Her career trajectory demonstrates steady growth, with key achievements and contributions in each role. At UCB, she served as Head of Innovative Solutions and Assessments, Neurology New Patient Solutions, and Mission Head Towards better outcome for epilepsy patients, showcasing her dedication to improving patient outcomes. Earlier in her career, she held roles at Johnson & Johnson, including Compound Development Team Leader and Site Director Clinical Pharmacokinetics.

Areas of Expertise

Nancy Van Osselaer's areas of expertise include strategic consultancy, drug development, innovation, project leadership, and team management. Her technical competencies span clinical pharmacokinetics, compound development, and early development project leadership. As a seasoned leader, she possesses strong management capabilities, with experience in supervising teams and driving strategic growth.

Professional Impact

Throughout her career, Nancy Van Osselaer has made significant contributions to the Life Sciences and Healthcare industry. Her work has focused on developing innovative solutions, improving patient outcomes, and driving strategic partnerships. While specific metrics are not available, her dedication to the industry and her commitment to excellence have had a lasting impact on the companies she has worked with and the patients they serve.

Conclusion

Nancy Van Osselaer's professional trajectory is marked by steady growth, dedication, and a commitment to excellence. Currently, she is focused on driving innovation and strategic growth in the Life Sciences and Healthcare sector. As a seasoned professional with a unique blend of technical expertise and leadership capabilities, she offers a valuable proposition to companies seeking to develop innovative solutions and improve patient outcomes.